Pharma & Drug Safety

Salt of the Earth Cream Recalled Due to Chemical Hazard

Health Canada has issued a consumer product recall for Salt of the Earth Cedar and Amyris Replenish Cream due to a chemical hazard. The product contains methyl eugenol above the maximum concentration allowed by the Cosmetic Ingredient Hotlist. Consumers are advised to stop using the product immediately.

ZoRaw Milk Chocolate Recalled for Undeclared Almond and Peanut

The Canadian Food Inspection Agency has issued a recall for ZoRaw brand Milk Chocolate products due to undeclared almond and peanut allergens. Consumers are advised not to consume the affected products.

Primal Herbs Recalls Volume Due to Undeclared Sildenafil

Primal Supplements Group LLC is voluntarily recalling all orders of Primal Herbs Volume due to the undeclared presence of sildenafil, an active ingredient in Viagra. The FDA confirmed the undeclared ingredient, which poses a risk of dangerous blood pressure drops when interacting with nitrates.

DEA Extensions, eRX Fraud Prevention, HB25 Enacted

This notice from the Texas State Board of Pharmacy (TSBP) covers several key updates. It mentions the enactment of HB25, extensions related to the DEA, and measures for e-prescribing fraud prevention. The content appears to be a summary of recent regulatory and legislative changes relevant to pharmacy practice.

Rule, Disciplinary Action, & Remedial Plan Summaries

Rule, Disciplinary Action, & Remedial Plan Summaries

Texas Pharmacy and Medical Boards Joint Statement on Communication

The Texas Medical Board and Texas State Board of Pharmacy issued a joint statement reminding physicians and pharmacists of the importance of clear communication and collaboration in patient care. The statement emphasizes professional judgment and shared responsibility in ensuring safe and legitimate prescription practices.

Texas Pharmacy Rules Updated

The Texas State Board of Pharmacy has updated its rules following a recent board meeting. This notice serves to inform stakeholders about the changes made to existing pharmacy regulations.

Professional Recovery Network, Fees and CE Updates

Professional Recovery Network, Fees and CE Updates

WHO Releases New Antibiotic Profiles for Drug-Resistant Infections

The World Health Organization (WHO) has released three new Target Product Profiles (TPPs) for antibacterial agents to address critical drug-resistant infections. These profiles guide the development of new antibiotics for multidrug-resistant Gram-negative infections, Gram-positive infections in vulnerable patients, and bacterial meningitis.

WHO Handbook Accelerates Hepatitis Elimination Action

The World Health Organization (WHO) has released a new implementation handbook to support countries in accelerating action towards hepatitis elimination by 2030. The handbook consolidates evidence-based recommendations and provides practical guidance for expanding prevention, testing, and treatment services.